NextGen Healthcare Names 2011 Best Practice Award Winners at Annual Users Group Meeting

Small, mid-sized and large practices are recognized at annual Users’ Group Meeting for innovative use of NextGen® solutions and achievement of significant ROI

ORLANDO, Fla. (November 16, 2011) – NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), and leading provider of healthcare information systems and connectivity solutions, this week revealed the recipients of its sixth annual Best Practice Awards. Winners were honored Monday evening at the NextGen Healthcare Users’ Group Meeting (UGM) in Las Vegas, Nev. before an audience of more than 4,200 attendees.

NextGen Healthcare’s Best Practice Awards acknowledge three clients for exemplary use of NextGen® solutions. This year, clients leveraged NextGen® Ambulatory EHR, NextGen® Practice Management, NextGen® Patient Portal, NextGen(TM) Health Information Exchange and NextGen(TM) Consulting Services to help transform their practices and achieve a significant return-on-investment:

  • Small Practice: Port Gamble S’Klallam Tribe, Kingston, Wash., implemented an evidence-based preventative care and chronic disease management program using NextGen
  • Mid-Size Practice: Drs. Goodman & Partridge, OB/GYN, Chandler, Ariz., leveraged the ability to make critical patient information readily available, searchable and reportable to improve its efficiency and become the largest OB/GYN practice in Arizona. The practice has saved more than $1.5 million in staff hours and office supplies, and in a recent seven-month period increased revenue by 26.36 percent and decreased A/R time by 76 days.
  • Large Practice: Nautilus Healthcare Management Group, Newport Beach, Calif., used virtually all NextGen

About NextGen Healthcare

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. For more information, please visit and Follow NextGen Healthcare on Twitter at or Facebook at

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company’s ability or inability to attract and retain qualified personnel; possible regulation of the Company’s software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods’ financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems’ periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company’s quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company’s revenues and operating results are very difficult to forecast. A major portion of the Company’s costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company’s period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.


NextGen and NextPen are either registered trademarks or trademarks of NextGen Healthcare Information Systems, Inc. in the United States and/or other countries. All other names and marks are property of their respective owners.

Patent pending.

Source: NextGen Healthcare